The cytotoxicity of chromium in osteoblasts: effects on macromolecular synthesis
- PMID: 15348204
- DOI: 10.1023/a:1013630401959
The cytotoxicity of chromium in osteoblasts: effects on macromolecular synthesis
Abstract
Exposure of an immortalized rat osteoblast cell line, FFC cells, to Cr VI resulted in inhibition of protein, DNA and RNA synthesis. Protein synthesis (3H-leucine incorporation) was most sensitive. There was no inhibition of the incorporation of 3H-proline into collagen at the concentrations which inhibited general protein synthesis (1 microM), but synthesis of extracellular collagen fibers was markedly decreased by concentrations of 0.5 microM Cr VI and above. This indicates that some aspect of the post-translational processing of the collagen fibers is sensitive to Cr VI inhibition. Collagen fiber formation was not inhibited by Cr III (which does not penetrate the cell membrane) or when Cr VI was reduced to Cr III extracellularly. This suggests that the Cr VI inhibits an intracellular stage of post-translational collagen processing. Both Cr VI and Cr III inhibit collagenase activity, the former being more potent but less efficacious. Our results suggest that leakage of chromium ions from orthopedic implants may cause a decrease in the proliferation and infiltration of osteoblasts around the implant, and a reduction in the synthesis and altered turnover of collagen in extracellular matrix. These effects will influence the osseointegration of implants, the osteolytic response, and ultimately the stable life-time of the implants.
Similar articles
-
Chromium (VI)-induced cytotoxicity to osteoblast-derived cells.Toxicol In Vitro. 1999 Dec;13(6):879-87. doi: 10.1016/s0887-2333(99)00075-2. Toxicol In Vitro. 1999. PMID: 20654563
-
The role of reduced glutathione and glutathione reductase in the cytotoxicity of chromium (VI) in osteoblasts.Toxicol In Vitro. 2000 Aug;14(4):329-35. doi: 10.1016/s0887-2333(00)00024-2. Toxicol In Vitro. 2000. PMID: 10906439
-
Cytotoxic and clastogenic effects of soluble and insoluble compounds containing hexavalent and trivalent chromium.Br J Cancer. 1981 Aug;44(2):219-35. doi: 10.1038/bjc.1981.173. Br J Cancer. 1981. PMID: 7272188 Free PMC article.
-
Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review).Oncol Rep. 1998 Nov-Dec;5(6):1307-18. doi: 10.3892/or.5.6.1307. Oncol Rep. 1998. PMID: 9769362 Review.
-
Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.Toxicology. 2014 Nov 5;325:160-79. doi: 10.1016/j.tox.2014.08.009. Epub 2014 Aug 28. Toxicology. 2014. PMID: 25174529 Review.
Cited by
-
Chromium and cobalt ion concentrations in blood and serum following various types of metal-on-metal hip arthroplasties: a literature overview.Acta Orthop. 2013 Jun;84(3):229-36. doi: 10.3109/17453674.2013.792034. Epub 2013 Apr 18. Acta Orthop. 2013. PMID: 23594249 Free PMC article. Review.
-
Trivalent chromium versus baricitinib for rheumatoid arthritis treatment: first phase 2/3 randomized controlled trial, is trivalent chromium the upcoming immune-modulator?Inflammopharmacology. 2024 Oct;32(5):3163-3179. doi: 10.1007/s10787-024-01515-x. Epub 2024 Jul 19. Inflammopharmacology. 2024. PMID: 39030450 Free PMC article. Clinical Trial.
-
Release of chromium from orthopaedic arthroplasties.Open Orthop J. 2008 Jan 24;2:10-8. doi: 10.2174/1874325000802010010. Open Orthop J. 2008. PMID: 19461924 Free PMC article.
-
Applications of Metals for Bone Regeneration.Int J Mol Sci. 2018 Mar 12;19(3):826. doi: 10.3390/ijms19030826. Int J Mol Sci. 2018. PMID: 29534546 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources